1010 related articles for article (PubMed ID: 27899487)
21. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
[TBL] [Abstract][Full Text] [Related]
22. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
[TBL] [Abstract][Full Text] [Related]
23. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
[TBL] [Abstract][Full Text] [Related]
24. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
25. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
[TBL] [Abstract][Full Text] [Related]
26. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
[TBL] [Abstract][Full Text] [Related]
27. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
28. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
29. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
[TBL] [Abstract][Full Text] [Related]
30. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
31. PLVAP as an Early Marker of Glomerular Endothelial Damage in Mice with Diabetic Kidney Disease.
Wolf EE; Steglich A; Kessel F; Kröger H; Sradnick J; Reichelt-Wurm S; Eidenschink K; Banas MC; Wolf E; Wanke R; Gembardt F; Todorov VT
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674624
[TBL] [Abstract][Full Text] [Related]
32. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
33. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
34. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.
Miyata KN; Zhao XP; Chang SY; Liao MC; Lo CS; Chenier I; Ethier J; Cailhier JF; Lattouf JB; Troyanov S; Chiasson JL; Ingelfinger JR; Chan JSD; Zhang SL
Transl Res; 2020 Mar; 217():1-10. PubMed ID: 31794697
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
37. SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease.
Guo F; Song Y; Wu L; Zhao Y; Ma X; Wang J; Shao M; Ji H; Huang F; Fan X; Wang S; Qin G; Yang B
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166685. PubMed ID: 36889557
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial dysfunction in diabetic kidney disease.
Wei PZ; Szeto CC
Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
[TBL] [Abstract][Full Text] [Related]
39. Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.
Srivastava SP; Zhou H; Setia O; Dardik A; Fernandez-Hernando C; Goodwin J
J Am Heart Assoc; 2021 Aug; 10(15):e019437. PubMed ID: 34308664
[TBL] [Abstract][Full Text] [Related]
40. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
